---
{"dg-publish":true,"permalink":"/entities/condition/subclinical-hypothyroidism/","tags":["condition","endocrinology","thyroid","metabolic","function-health"]}
---


# Subclinical Hypothyroidism

## Overview

Subclinical Hypothyroidism (SCH) is defined biochemicaly as an elevated serum **TSH** with a normal **Free T4**. It is often a precursor to overt hypothyroidism. Treatment is controversial, especially for TSH levels < 10 mIU/L, and is often based on the presence of symptoms, age, or pregnancy status.

## Clinical Considerations

- **Progression:** 2â€“5% of patients per year progress to overt hypothyroidism, especially those with positive **TPO Antibodies**.
- **Cardiovascular Risk:** Linked to increased risk of heart failure and coronary heart disease when TSH > 10.
- **Pregnancy:** Requires aggressive management to prevent fetal developmental issues.

## Relationships

ASSOCIATED_WITH_CONDITION::[[Hypothyroidism\|Hypothyroidism]]
ASSOCIATED_WITH_CONDITION::[[entities/condition/Hashimotos Thyroiditis\|Hashimotos Thyroiditis]]
ASSOCIATED_WITH_CONDITION::[[Dyslipidemia\|Dyslipidemia]]
AFFECTS_ORGAN::[[Thyroid Gland\|Thyroid Gland]]
ASSOCIATED_WITH_BIOMARKER::[[entities/labtest/tsh\|TSH]] - Elevated.
ASSOCIATED_WITH_BIOMARKER::[[entities/biomarker/Free T4\|Free T4]] - Normal.
ASSOCIATED_WITH_BIOMARKER::[[entities/biomarker/Tpo Antibodies\|Tpo Antibodies]]
TREATED_BY_DRUG::[[entities/drug/Levothyroxine\|Levothyroxine]]

## References

- Peeters, R. P. (2017). Subclinical Hypothyroidism. NEJM.
- Mayo Clinic. Subclinical hypothyroidism.
- ATA. Subclinical Hypothyroidism FAQ.
